These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 10472420

  • 1. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
    Lindström LH, Gefvert O, Hagberg G, Lundberg T, Bergström M, Hartvig P, Långström B.
    Biol Psychiatry; 1999 Sep 01; 46(5):681-8. PubMed ID: 10472420
    [Abstract] [Full Text] [Related]

  • 2. Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.
    Nozaki S, Kato M, Takano H, Ito H, Takahashi H, Arakawa R, Okumura M, Fujimura Y, Matsumoto R, Ota M, Takano A, Otsuka A, Yasuno F, Okubo Y, Kashima H, Suhara T.
    Schizophr Res; 2009 Mar 01; 108(1-3):78-84. PubMed ID: 19056247
    [Abstract] [Full Text] [Related]

  • 3. Presynaptic dopaminergic function in the striatum of schizophrenic patients.
    Dao-Castellana MH, Paillère-Martinot ML, Hantraye P, Attar-Lévy D, Rémy P, Crouzel C, Artiges E, Féline A, Syrota A, Martinot JL.
    Schizophr Res; 1997 Feb 07; 23(2):167-74. PubMed ID: 9061812
    [Abstract] [Full Text] [Related]

  • 4. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M.
    Arch Gen Psychiatry; 2010 Mar 07; 67(3):231-9. PubMed ID: 20194823
    [Abstract] [Full Text] [Related]

  • 5. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C, Tseng HH, Kenk M, Tagore A, Kiang M, Wilson AA, Houle S, Rusjan PM, Mizrahi R.
    Brain; 2018 Jul 01; 141(7):2213-2224. PubMed ID: 29860329
    [Abstract] [Full Text] [Related]

  • 6. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR.
    Neuropsychopharmacology; 2000 Feb 01; 22(2):125-32. PubMed ID: 10649825
    [Abstract] [Full Text] [Related]

  • 7. Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]DOPA.
    Ota M, Yasuno F, Ito H, Seki C, Nozaki S, Asada T, Suhara T.
    Life Sci; 2006 Jul 17; 79(8):730-6. PubMed ID: 16580023
    [Abstract] [Full Text] [Related]

  • 8. Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response.
    Tedroff J, Aquilonius SM, Hartvig P, Bredberg E, Bjurling P, Långström B.
    Acta Neurol Scand; 1992 Feb 17; 85(2):95-102. PubMed ID: 1574995
    [Abstract] [Full Text] [Related]

  • 9. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
    Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rösch F, Cumming P, Mann K, Bartenstein P, Heinz A.
    Eur J Neurosci; 2006 Jul 17; 24(1):305-13. PubMed ID: 16882026
    [Abstract] [Full Text] [Related]

  • 10. Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.
    Hartvig P, Agren H, Reibring L, Tedroff J, Bjurling P, Kihlberg T, Långström B.
    J Neural Transm Gen Sect; 1991 Jul 17; 86(1):25-41. PubMed ID: 1751027
    [Abstract] [Full Text] [Related]

  • 11. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
    Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ.
    Arch Gen Psychiatry; 1997 Dec 17; 54(12):1089-95. PubMed ID: 9400344
    [Abstract] [Full Text] [Related]

  • 12. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
    Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF.
    Nat Neurosci; 2002 Mar 17; 5(3):267-71. PubMed ID: 11865311
    [Abstract] [Full Text] [Related]

  • 13. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ, REAL-PET Study Group.
    Ann Neurol; 2003 Jul 17; 54(1):93-101. PubMed ID: 12838524
    [Abstract] [Full Text] [Related]

  • 14. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.
    Fusar-Poli P, Meyer-Lindenberg A.
    Schizophr Bull; 2013 Jan 17; 39(1):33-42. PubMed ID: 22282454
    [Abstract] [Full Text] [Related]

  • 15. Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography.
    Tedroff J, Aquilonius SM, Hartvig P, Lundqvist H, Bjurling P, Långström B.
    Acta Neurol Scand; 1992 Mar 17; 85(3):166-73. PubMed ID: 1574997
    [Abstract] [Full Text] [Related]

  • 16. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
    Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR.
    Biol Psychiatry; 1999 Mar 15; 45(6):660-7. PubMed ID: 10187995
    [Abstract] [Full Text] [Related]

  • 17. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
    Kaasinen V, Någren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO.
    Neurology; 2000 Apr 11; 54(7):1482-7. PubMed ID: 10751262
    [Abstract] [Full Text] [Related]

  • 18. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
    Torstenson R, Tedroff J, Hartvig P, Fasth KJ, Långström B.
    J Cereb Blood Flow Metab; 1999 Oct 11; 19(10):1142-9. PubMed ID: 10532639
    [Abstract] [Full Text] [Related]

  • 19. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.
    Arch Neurol; 1995 Dec 11; 52(12):1183-90. PubMed ID: 7492293
    [Abstract] [Full Text] [Related]

  • 20. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.
    Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ.
    Brain; 2002 Jun 11; 125(Pt 6):1358-65. PubMed ID: 12023324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.